2nd GCP Inspection Readiness, Leverage Tools, Training, and Technology to Achieve a Confident State of GCP Inspection Readiness, December 4-6, 2023, Hybrid Event, Philadelphia

Our 2022 Advisory Board

Allison Duran
Allison Duran

Associate Director, Clinical Oversight and Optimization
SANGAMO THERAPEUTICS

David Fryrear
David Fryrear

Executive Vice President, Head of Quality Assurance
ASTELLAS

Celeste M. Gonzalez, BS, CVT, RQAP-GCP, CCRP
Celeste M. Gonzalez, BS, CVT, RQAP-GCP, CCRP

Principal
CLINICAL QA INTERNATIONAL, LLC

Sheila Gwizdak, M.S.
Sheila Gwizdak, M.S.

Vice President, Quality
HALLORAN CONSULTING GROUP

Dawn Lundin
Dawn Lundin

Head of Global Quality
MAPS PBC

Crissy MacDonald, Ph.D.
Crissy MacDonald, Ph.D.

Vice President, Client Delivery
WCG AVOCA

Dawn Niccum
Dawn Niccum

Executive Director, QA and Compliance
INSEPTION GROUP

Sharon Reinhard
Sharon Reinhard

Vice President, Global Quality
AVROBIO

Tim Stoddard
Tim Stoddard
Quality Consultant/Advisor; Previous Head of Quality,
FLATIRON HEALTH
Previous Clinical Quality Leader
SPARK THERAPEUTICS
Michele Weitz
Michele Weitz

Executive Director, Clinical Standards and Innovation
CLOVIS ONCOLOGY